Clear cell mesothelioma presenting as an incarcerated abdominal hernia

Virchows Archiv

Volumn 447, Issue 5, 2005, Pages 823-827

  Ordóñez, Nelson G ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Clear cell mesothelioma; D2 40; Hernia; Immunohistochemistry; Podoplanin

Indexed keywords

ABDOMINAL WALL HERNIA; AGED; ARTICLE; CASE REPORT; CLEAR CELL CARCINOMA; CLINICAL FEATURE; DISEASE COURSE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MESOTHELIOMA; PRIORITY JOURNAL;

AGED; DIAGNOSIS, DIFFERENTIAL; GLYCOGEN; HERNIA, ABDOMINAL; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MESOTHELIOMA; PERITONEAL NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 28444460402     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-005-0023-2     Document Type: Article

References (28)

1. Acherman YIZ, Welch LS, Bromley CM, Sugarbaker PH (2003) Clinical presentation of peritoneal mesothelioma. Tumori 89:269-273
2. Aggarwal M, Lakhar B, Shetty D, Ullal S (2000) Malignant peritoneal mesothelioma in an inguinal hernial sac: an unusual presentation. Indian J Cancer 37:91-94
3. Bethwaite PB, Evans R, Naik DK, Delahunt B, Teague CA (1996) Diffuse malignant mesothelioma arising in a paracolostomy hernial sac. Histopathology 29:282-284
4. Breiteneder-Geleff S, Matsui K, Soleiman A, Meraner P, Poczewski H, Kalt R, Schaffner G, Kerjaschki D (1997) Podoplanin, novel 43-kd membrane protein of glomerular epithelial cells, is down-regulated in puromycin nephrosis. Am J Pathol 151:1141-1152
5. Breiteneder-Geleff S, Soleiman A, Kowalski H, Horvat R, Amann G, Kriehuber E, Diem K, Weninger W, Tschachler E, Alitalo K, Kerjaschki D (1999) Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium. Am J Pathol 154:385-394
6. Cavazza A, Pasquinelli G, Agostini L, Leslie KO, Colby TV (2002) Foamy cell mesothelioma (Letter). Histopathology 41:369-371
7. Chang HT, Yantiss RK, Nielsen GP, McKee GT, Mark EJ (2000) Lipid-rich diffuse malignant mesothelioma: a case report. Hum Pathol 31:876-879
8. Chu AY, Litzky LA, Pasha TL, Acs G, Zhang PJ (2005) Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma. Mod Pathol 18:105-110
9. Dessy E, Falleni M, Braidotti P, Del Curto B, Panigalli T, Pietra GG (2001) Unusual clear cell variant of epithelioid mesothelioma. Arch Pathol Lab Med 125:1588-1590
10. Grove A, Jensen ML, Donna A (1989) Mesotheliomas of the tunica vaginalis testis and hernial sacs. Virchows Archiv A Pathol Anat 415:283-292
11. Kerrigan SAJ, Cagle P, Churg A (2003) Malignant mesothelioma of the peritoneum presenting as an inflammatory lesion. Am J Surg Pathol 27:248-253
12. Kahn HJ, Bailey D, Marks A (2002) Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcomas. Mod Pathol 15:434-440
13. Kahn HJ, Marks A (2002) A new monoclonal antibody, D2-40, for detection of lymphatic invasion in primary tumors. Lab Invest 82:1255-1257
14. Kaufmann O, Fietze E, Mengs J, Dietel M (2001) Value of p63 and cytokeratin 5/6 as immunohistochemical markers for the differential diagnosis of poorly differentiated and undifferentiated carcinomas. Am J Clin Pathol 116:823-830
15. Kimura N, Kimura I (2005) Podoplanin as a marker for mesothelioma. Pathol Int 55:83-86
16. Marks A, Sutherland DR, Bailey D, Iglesias J, Law J, Lei M, Yeger H, Banerjee D, Baumal R (1999) Characterization and distribution of an oncofetal antigen (M2A antigen) expressed on testicular germ cell tumours. Br J Cancer 80:569-578
17. McGregor DK, Khurana KK, Cao C, Tsao CC, Ayala G, Krishnan B, Ro JY, Lechago J, Truong LD (2001) Diagnosing primary and metastatic renal cell carcinoma: The use of the monoclonal antibody "Renal Cell Carcinoma Marker". Am J Surg Pathol 25:1485-1492
18. Mirabella F (1996) Peritoneal mesothelioma and abdominal hernias. Minerva Med 87:21-24
19. Ordóñez NG (2003) The immunohistochemical diagnosis of mesothelioma: a comparative study of epithelioid mesothelioma and lung adenocarcinoma. Am J Surg Pathol 27:1031-1051
20. Ordóñez NG (2004) The diagnostic utility of immunohistochemistry in distinguishing between mesothelioma and renal cell carcinoma: a comparative study. Hum Pathol 35:697-710
21. Ordóñez NG (2005) D2-40 and podoplanin are highly specific and sensitive immunohistochemical markers of epithelioid malignant mesothelioma. Hum Pathol 36:372-380
22. Ordóñez NG (2005) The diagnostic utility of immunohistochemistry and electron microscopy in distinguishing between peritoneal mesotheliomas and serous carcinomas: a comparative study. Mod Pathol (in press)
23. Ordóñez NG, Mackay B (1999) Glycogen-rich mesothelioma. Ultrastruct Pathol 23:401-406
24. Ordóñez NG, Myhre M, Mackay B (1996) Clear cell mesothelioma. Ultrastruct Pathol 20:331-336
25. Pan C-C, Chen PC-H, Chou T-Y, Chiang H (2003) Expression of calretinin and other mesothelioma-related markers in thymic carcinoma and thymoma. Hum Pathol 34:1155-1162
26. Reis-Filho JS, Simpson PT, Martins A, Preto A, Gärtner F, Schmitt FC (2003) Distribution of p63, cytokeratins 5/6 and cytokeratin 14 in 51 normal and 400 neoplastic human tissue samples using TARP-4 multi-tumor tissue microarray. Virchows Arch 443:122-132
27. Tang CK, Gray GF, Keuhnelian JG (1976) Malignant peritoneal mesothelioma in an inguinal hernia sac. Cancer 37:1887-1890
28. Wu M, Wang B, Gil J, Sabo E, Miller L, Gan L, Burstein DE (2003) p63 and TTF-1 immunostaining. A useful marker panel for distinguishing small cell carcinoma of lung from poorly differentiated squamous cell carcinoma of lung. Am J Clin Pathol 119:696-702